$599

Dexcom Q4 ’17 Earnings Update

Dexcom hosted its Q4 ’17 earnings call and provided updates to its CGM business. Of note, Dexcom disclosed that while they are working with FDA on not requiring calibrations for G6, it will still allow calibrations if the user chooses. Below are highlights from the call.

This content is for Read Less members only.
Register
Already a member? Log in here